Peijia Medical Limited (FRA:4WO)

Market Cap	476.07M +53.0%
Revenue (ttm)	79.36M +29.0%
Net Income	-26.77M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	222
Open	0.6950
Previous Close	0.7000
Day's Range	0.6950 - 0.6950
52-Week Range	0.4180 - 1.0100
Beta	n/a
RSI	49.09
Earnings Date	Mar 25, 2026

About Peijia Medical

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People’s Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company products include transcatheter aortic valve replacement (TAVR) systems, crosslinked dry-tissue and polymeric tri leaflet TAVR systems, transcatheter aortic valve sys...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2012
• Employees: 1,035
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4WO

Financial Performance

In 2024, Peijia Medical's revenue was 615.48 million, an increase of 39.53% compared to the previous year's 441.13 million. Losses were -226.58 million, -42.28% less than in 2023.

Financial numbers in CNY